On ECHEMI
Home > Drugs > Hypersplenism
Hypersplenism
Hypersplenism (abbreviated as hypersplenism) is a syndrome caused by different diseases that cause splenomegaly and hemocyte reduction. The clinical manifestations are splenomegaly, one or more hemocyte reductions, and corresponding proliferation of bone marrow hematopoietic cells, which can be relieved by splenectomy. After the treatment of the primary disease, the clinical symptoms of some cases can be alleviated. It is generally believed that hypersplenism is often accompanied by varying degrees of splenomegaly. This enlarged spleen has a retention effect on blood cells, and the proliferation of splenic sinuses enhances the phagocytosis and destruction of blood cells, which is an important cause of the clinical manifestations of hypersplenism. After splenectomy, the clinical symptoms can be corrected.
  • Site of disease:

    spleen
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Hepatosplenomegaly Spleen and kidney yang deficiency Bleeding tendency Yellow or brown nose Panemia
  • Concurrent disease:

Related Drugs
Acanthopanax Tablets
Manufacturer:

Zhongshan Kekekang Pharmaceutical Co., Ltd.

Danggui Buxue Wan
Manufacturer:

Guangdong Heping Pharmaceutical Co., Ltd.

Acanthopanax Granules
Manufacturer:

Heilongjiang Nojie Pharmaceutical Co., Ltd.

Donkey glue blood-replenishing granules
Manufacturer:

Jiuzhitang Co., Ltd.

Fufang Hexue Pills
Manufacturer:

Jilin Yuren Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.